Full access to Entrepreneur for $5

Company News for Sep 9, 2021

Companies In The News Are: COIN, TSLA, SPB, ICUI

This story originally appeared on Zacks
  • Shares of Coinbase Global, Inc. COIN fell 3.2% after the company announced that it has received from the Securities and Exchange Commission, a notice for possible enforcement action with regard to its interest-lending product, namely, Coinbase Lend.
  • Tesla, Inc.’s TSLA shares rose 0.1% following news that local sales of China-made vehicles increased to 12,885 in August, compared to 8,621 vehicles in July.
  • Spectrum Brands Holdings, Inc.’s SPB shares rallied 17.8% after the company announced that it has planned to sell its Hardware & Home Improvement segment to ASSA ABLOY AB for $4.3 billion in cash.
  • ICU Medical, Inc.’s ICUI shares advanced 26.2% following the announcement that the company will acquire Smiths Medical which manufactures medical products, for about $2.3 billion in cash and stock.

Breakout Biotech Stocks with Triple-Digit Profit Potential

- Zacks

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


ICU Medical, Inc. (ICUI): Free Stock Analysis Report


Tesla, Inc. (TSLA): Free Stock Analysis Report


Spectrum Brands Holdings Inc. (SPB): Free Stock Analysis Report


Coinbase Global, Inc. (COIN): Free Stock Analysis Report


To read this article on Zacks.com click here.


Zacks Investment Research